Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity

Vivek Puri ¹, Manju Nagpal ¹ * , Ameya Sharma ¹, Gurjeet Singh Thakur ¹, Manjinder Singh ¹, Geeta Aggarwal ²

Cited by CrossRef: 2

1- Haji Ali B, Shirvaliloo M, Fathi‐Karkan S, Mirinejad S, Ulucan‐Karnak F, Sargazi S, Sargazi S, Sheervalilou R, Rahman M. Nanotechnology‐Based Strategies for Extended‐Release Delivery of Angiotensin Receptor Blockers (ARBs): A Comprehensive Review. Chemistry & Biodiversity. 2023;20(11) [Crossref]

2- Farias M, da Silva P, Tavares M, Monteiro M. Development of polyvinylpyrrolidone, inorganic nanoparticles, and lithium carbonate nanostructured systems. Polymer Engineering & Sci. 2023;63(9):3037 [Crossref]

3- Dudhipala N, Ettireddy S, Youssef A, Puchchakayala G. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization. Molecules. 2021;26(24):7538 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons